Ascendis Pharma
ASND
#1285
Rank
C$23.86 B
Marketcap
C$363.88
Share price
-0.81%
Change (1 day)
22.14%
Change (1 year)

EPS for Ascendis Pharma (ASND)

EPS in 2026 (TTM): C$19.11

According to Ascendis Pharma 's latest financial reports the company's current EPS (TTM) is C$19.58. In 2025 the company made an earnings per share (EPS) of C-$6.14 an increase over its 2024 EPS that were of C-$10.20.

EPS history for Ascendis Pharma from 2023 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C$19.11-411.35%
2025C-$6.14-39.79%
2024C-$10.20-23.17%
2023C-$13.27

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Akebia Therapeutics
AKBA
C-$0.23-101.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Affimed
AFMD
C-$7.49-138.26%๐Ÿ‡ฉ๐Ÿ‡ช Germany
Advaxis
ADXS.defunct
C-$13.89-170.93%๐Ÿ‡บ๐Ÿ‡ธ USA